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RemifentanilAbstract Maintaining higher sedation in patients undergoing ECMO therapy is crucial. Currently
no definite sedation strategy has been proposed in the literature, as the pharmacokinetics of the
medications in these patients is still not clear. We would like to report a case of a patient with
uncontrollable diverse clinical response to medications during arteriovenous (AV) compared to
venovenous (VV) ECMO.
 2016 The Egyptian College of Critical Care Physicians. Production and hosting by Elsevier B.V. All
rights reserved.1. Case report
A 25 year old woman was on mechanical ventilation due to
refractory respiratory failure possibly a H1N1 influenza infec-
tion. Her general condition worsened with decline in arterial
pressure requiring escalating doses of noradrenaline with
echocardiographic evidence of impaired right ventricle with
severe pulmonary hypertension. She was also found to have
moderate mixed mitral disease and mild aortic stenosis. Due
to unstable hemodynamics in addition to worsening pul-
monary function, ECMO A-V was commenced under generalanesthesia. An inflow catheter was inserted into the right
femoral artery (19 Fr) and the left femoral vein (19 Fr) was
used as the returning port. As expected heparin requirement
for the treatment gradually rose over the next 2 days with an
infusion rate of 3000–5500 units/h to achieve the target ACT.
As days progressed the heparin requirement increased to astro-
nomical figures up to a maximum of 7800 units/h to achieve
the target with serum antithrombin levels remaining normal
(110%). Frozen plasma was administered with no benefits.
Her sedation requirement started to increase requiring a
propofol infusion of 5000 mgm/h, midazolam 25 mg/h despite
remifentanil infusion. Sedation was supplemented with Dex-
ametodimidine and cisatracurium paralysis. She also devel-
oped irresistible severe hypertension requiring large doses of
sodium nitroprusside leading to consequent bleeding from
arterial catheter site further requiring multiple transfusions.
To prevent the ongoing massive transfusion and the possibility
of femoral arterial tear and avulsion of catheter, AV was
swapped for the VV for the rest of the treatment. The inflow
catheter was changed from the right femoral artery to the right
internal jugular vein (Fr 19). Surprisingly, as soon as the VV
Figure 1 VV ECMO was discontinued after 4 days and returned to conventional ventilation.
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with better control of her arterial pressure requiring minimal
doses of noradrenaline. She made a good progress from then
on and the VV ECMO was discontinued after 4 days and
returned to conventional ventilation (see Fig. 1).
2. Discussion
Few reports from the literature showed increased requirement
to sedation due to differences in PKa, hemodilution, drug
sequestration, tolerance, genetic factors. . .etc [1] and are
mostly done in children. Heparin requirement has been vari-
able for the similar reasons and the antithrombin deficiency
due to prolonged use. It is also well known that perfusion
and oxygenation are different in two extremities while on
AV ECMO. Unfortunately most of these studies showed
higher drug requirements for sedation and the hypertension
is more pronounced in VV compared to AV ECMO [2]. Con-trary to the above findings, our patient had hypertension
requiring magnanimous doses of sedation and the risk of
bleeding and vascular complication necessitating the change
of VA to VV. The excessive heparin requirements with normal
antithrombin levels slowed down after few days while on AV
ECMO. The role of heparin sequestration is questionable as
we have used heparin coated standard sized PVC tubes. Fur-
ther research is necessary to understand the mechanism and
to identify the most suitable drugs during ECMO.
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